Robust real-world data on the effectiveness of biologic therapies in children with severe asthma remain limited, particularly ...
MedPage Today on MSN
FDA Approves Generic Flovent Inhaler for Asthma
Move comes 2 years after controversial exit of brand-name product ...
Nonclinical factors are more likely to drive discontinuation of biologic therapy for patients with severe asthma.
Among patients with asthma without diabetes, the risk for exacerbation was decreased with GLP-1 receptor agonist exposure, ...
Asthma biologic use was not associated with an increase in respiratory infection risk, according to results from the 2026 ...
Children with food allergy who used omalizumab plus oral immunotherapy vs. omalizumab alone had similar rates of allergen ...
This chronic lung condition causes your airways to become permanently widened and scarred. Learn how to spot and treat this ...
Study results suggest immune checkpoint inhibitor therapy may offer immunomodulatory benefits for patients with asthma and ...
A Professor of Medicine at the Lagos State University, LASU, Ojo, Professor Olufunke Olayinka Adeyeye, has said no fewer than 13 million Nigerians suffer from Asthma, a respiratory disease.
For patients with asthma, receipt of immune checkpoint inhibitor (ICI) therapy for melanoma or renal cell carcinoma is not ...
JACKSON , MS, UNITED STATES, March 10, 2026 /EINPresswire.com/ -- As the warmer weather of spring approaches, so does ...
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced new data from its sebetralstat clinical trial program presented ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results